Morbidities associated with acromegaly, such as sleep apnea, cardiomyopathy, and glucose intolerance—contributing to a shortened life expectancy—tend to show improvement upon normalization of GH and IGF-1 levels [3]. This evidence concerns the gene GH1 and acromegaly.